Inflammation Beats Cholesterol: A Comment on the Unequivocal Driver of Cardiovascular Disease Risk
- PMID: 37048603
- PMCID: PMC10094835
- DOI: 10.3390/jcm12072519
Inflammation Beats Cholesterol: A Comment on the Unequivocal Driver of Cardiovascular Disease Risk
Abstract
Despite advancements in the current standard of care, cardiovascular diseases continue to hold the top spot as the leading cause of mortality worldwide. The development of atherosclerosis is the most common culprit behind ailments such as myocardial infarction, stroke, and peripheral vascular disease. Consequently, it imposes a significant burden on life expectancy, quality of life, morbidity, and societal costs. Both increased cholesterol levels and the activation of the inflammatory cascade are known as cardiovascular risk facts. Their relative weight is in the spotlight of curent biomedical research. Newly published data shed light on the role of inflammation in determining cardiovascular risk irrespective of cholesterol levels and cholesterol-lowering therapies.
Keywords: atherosclerosis; cardiovascular risk; inflammation; statins.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy.Int J Cardiol. 2013 Oct 15;168(6):5126-34. doi: 10.1016/j.ijcard.2013.07.113. Epub 2013 Aug 24. Int J Cardiol. 2013. PMID: 23978367 Review.
-
Statins in the 21st century: end of the simple story?Expert Opin Investig Drugs. 2001 Sep;10(9):1755-66. doi: 10.1517/13543784.10.9.1755. Expert Opin Investig Drugs. 2001. PMID: 11772284 Review.
-
Cardiovascular risk reduction: the future of cholesterol lowering drugs.Curr Opin Pharmacol. 2016 Apr;27:62-9. doi: 10.1016/j.coph.2016.01.007. Epub 2016 Mar 2. Curr Opin Pharmacol. 2016. PMID: 26939026 Review.
-
Lipoproteins and lipids in cardiovascular disease: from mechanistic insights to therapeutic targeting.Adv Drug Deliv Rev. 2020;159:4-33. doi: 10.1016/j.addr.2020.07.019. Epub 2020 Jul 27. Adv Drug Deliv Rev. 2020. PMID: 32730849 Review.
-
Emerging anti-inflammatory drugs for atherosclerosis.Expert Opin Emerg Drugs. 2013 Jun;18(2):193-205. doi: 10.1517/14728214.2013.801453. Epub 2013 May 16. Expert Opin Emerg Drugs. 2013. PMID: 23675745 Review.
Cited by
-
Flexible electronics for cardiovascular monitoring on complex physiological skins.iScience. 2024 Aug 12;27(9):110707. doi: 10.1016/j.isci.2024.110707. eCollection 2024 Sep 20. iScience. 2024. PMID: 39262772 Free PMC article. Review.
-
Factors involved in human healthy aging: insights from longevity individuals.Front Med. 2025 Apr;19(2):226-249. doi: 10.1007/s11684-024-1120-4. Epub 2025 Mar 22. Front Med. 2025. PMID: 40119024 Review.
-
Polydatin combined with hawthorn flavonoids alleviate high fat diet induced atherosclerosis by remodeling the gut microbiota and glycolipid metabolism.Front Pharmacol. 2025 Mar 3;16:1515485. doi: 10.3389/fphar.2025.1515485. eCollection 2025. Front Pharmacol. 2025. PMID: 40098615 Free PMC article.
-
The predictive value of the hs-CRP/HDL-C ratio, an inflammation-lipid composite marker, for cardiovascular disease in middle-aged and elderly people: evidence from a large national cohort study.Lipids Health Dis. 2024 Mar 1;23(1):66. doi: 10.1186/s12944-024-02055-7. Lipids Health Dis. 2024. PMID: 38429790 Free PMC article.
-
A Non-Coronary, Peripheral Arterial Atherosclerotic Disease (Carotid, Renal, Lower Limb) in Elderly Patients-A Review: Part I-Epidemiology, Risk Factors, and Atherosclerosis-Related Diversities in Elderly Patients.J Clin Med. 2024 Mar 3;13(5):1471. doi: 10.3390/jcm13051471. J Clin Med. 2024. PMID: 38592280 Free PMC article. Review.
References
-
- Thompson R.C., Allam A.H., Lombardi G.P., Wann L.S., Sutherland M.L., Sutherland J.D., Soliman M.A., Frohlich B., Mininberg D.T., Monge J.M., et al. Atherosclerosis across 4000 years of human history: The Horus study of four ancient populations. Lancet. 2013;381:1211–1222. doi: 10.1016/S0140-6736(13)60598-X. - DOI - PubMed
-
- Abdelfattah A., Allam A.H., Wann S., Thompson R.C., Abdel-Maksoud G., Badr I., Amer H.A., el-Din A.e.l.-H., Finch C.E., Miyamoto M.I., et al. Atherosclerotic cardiovascular disease in Egyptian women: 1570 BCE-2011 CE. Int. J. Cardiol. 2013;167:570–574. doi: 10.1016/j.ijcard.2012.01.082. - DOI - PubMed
-
- Nerlich A.G., Galassi F.M., Bianucci R. The Burden of Arteriosclerotic Cardiovascular Disease in Ancient Populations. In: Shin D., Bianucci R., editors. The Handbook of Mummy Studies. Springer; Singapore: 2021. - DOI
LinkOut - more resources
Full Text Sources